Abnormal localization of iron regulatory protein in Alzheimer's disease

Brain Research
M A SmithGeorge Perry

Abstract

A role for altered iron metabolism in the pathogenesis of Alzheimer's disease has been suggested by several reports associating the cardinal neuropathologic lesions with markers of free radical-induced damage and redox-active iron. We hypothesized that the abnormal distribution of iron in Alzheimer brain might result from alterations in iron regulatory proteins (IRP) such as IRP-1 and IRP-2, the main control elements of cellular iron homeostasis. Here, we report that while IRP-1 is present at similar levels in both Alzheimer and control brain tissue, IRP-2 shows striking differences and is associated with intraneuronal lesions, including neurofibrillary tangles, senile plaque neurites and neuropil threads. Since IRP-2 colocalizes with redox-active iron, our results suggest that alterations in IRP-2 might be directly linked to impaired iron homeostasis in Alzheimer's disease.

References

Jan 1, 1992·Journal of Neuroscience Research·J R ConnorE J Mufson
Jun 1, 1991·Lancet·D R Crapper McLachlanD F Andrews
Apr 18, 1991·Nature·R E Tanzi, B T Hyman
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·T A RouaultR D Klausner
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·G PerryV Chau
Apr 1, 1995·Trends in Neurosciences·M A SmithG Perry
Nov 15, 1994·The Biochemical Journal·E C Theil
Apr 1, 1994·Medical Hypotheses·M A Smith, G Perry
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·M A SmithG Perry
Mar 1, 1996·The Journal of Biological Chemistry·B R HendersonL C Kühn
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·J ButtT A Rouault
Jul 1, 1996·Molecular and Cellular Biology·K PantopoulosM W Hentze
Jul 11, 1996·Nature·M A SmithN Kowall
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·M W Hentze, L C Kühn
Aug 2, 1996·The Journal of Biological Chemistry·D J Selkoe
Jan 1, 1997·Experimental Neurology·C E Finch, D M Cohen
Sep 2, 1997·Proceedings of the National Academy of Sciences of the United States of America·M A SmithG Perry

❮ Previous
Next ❯

Citations

Feb 14, 2002·Archives of Biochemistry and Biophysics·Hani AtamnaBruce N Ames
Aug 9, 2011·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Yuanyuan QinWei Wang
Jan 16, 2014·Indian Journal of Clinical Biochemistry : IJCB·Hanaa H AhmedRania S Salah
Dec 2, 1999·FEBS Letters·K YamanakaK Iwai
Nov 16, 2001·Journal of Inorganic Biochemistry·R J WardR R Crichton
Feb 13, 2001·Neurobiology of Aging·J JosephM A Smith
Jul 27, 2001·Brain Research Bulletin·A CampbellG Perry
Jul 27, 2001·Brain Research Bulletin·K J ThompsonJ R Connor
Sep 12, 2001·Pediatric Neurology·J R ConnorP J Boyer
Jan 30, 1999·Journal of Chemical Neuroanatomy·M A Smith, G Perry
Apr 8, 2000·Free Radical Biology & Medicine·G PerryM A Smith
Feb 22, 2001·Free Radical Biology & Medicine·C A RottkampM A Smith
Jul 20, 2011·The British Journal of Nutrition·Martin Loef, Harald Walach
Feb 8, 2011·Metallomics : Integrated Biometal Science·David J BondaMark A Smith
Jun 15, 2000·Journal of Neurochemistry·K ChenM D Maines
Jun 18, 2002·Journal of Neurochemistry·Benoît ChénaisJean-Claude Drapier
Jul 19, 2002·Journal of Neurochemistry·Claudia Núñez-MillacuraMarco T Núñez
Oct 29, 2003·Antioxidants & Redox Signaling·Xiongwei ZhuMark A Smith
Mar 10, 2001·Antioxidants & Redox Signaling·R J CastellaniM A Smith
Sep 4, 2004·Antioxidants & Redox Signaling·Atsushi TakedaMark A Smith
Mar 11, 2008·Antioxidants & Redox Signaling·Elizabeth L MacKenzieYoshiaki Tsuji
Jan 26, 2010·Antioxidants & Redox Signaling·Orly WeinrebMoussa B H Youdim
Jun 13, 2000·Alzheimer Disease and Associated Disorders·C A RottkampM A Smith
Dec 21, 2006·Topics in Magnetic Resonance Imaging : TMRI·John F SchenckTimothy O'Keefe
Dec 21, 2006·Topics in Magnetic Resonance Imaging : TMRI·Daniela Berg, Moussa B H Youdim
Jun 2, 2000·Clinical Chemistry and Laboratory Medicine : CCLM·A K RainaM A Smith
Feb 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hani Atamna, Kathleen Boyle
Sep 23, 2006·Radiology·Anita RamaniJoseph A Helpern
Aug 7, 2013·Neuroscience Research·Hongkuan YangIkuo Tooyama
Jul 30, 2014·Frontiers in Pharmacology·Fatima Ali-RahmaniJames R Connor
Jul 9, 2014·Frontiers in Aging Neuroscience·Nakisa MalakootiDavid I Finkelstein
Apr 1, 2004·Brain Research·Xiongwei ZhuGeorge Perry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.